|
ZNF77 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20989999999421E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56486999999261E-05 |
| Normal-vs-Stage2 |
1.319610E-01 |
| Normal-vs-Stage3 |
2.27649999962054E-07 |
| Normal-vs-Stage4 |
2.16409999920231E-08 |
| Stage1-vs-Stage2 |
2.392200E-02 |
| Stage1-vs-Stage3 |
6.073900E-02 |
| Stage1-vs-Stage4 |
5.560500E-03 |
| Stage2-vs-Stage3 |
2.404400E-03 |
| Stage2-vs-Stage4 |
4.182700E-04 |
| Stage3-vs-Stage4 |
3.535200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37499999997015E-06 |
| Normal-vs-AfricanAmerican |
1.264910E-03 |
| Normal-vs-Asian |
1.51114999999979E-05 |
| Caucasian-vs-AfricanAmerican |
8.679000E-01 |
| Caucasian-vs-Asian |
9.532800E-01 |
| AfricanAmerican-vs-Asian |
8.556000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21730000002263E-06 |
| Normal-vs-Female |
2.14629999994997E-06 |
| Male-vs-Female |
7.594200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85226999999122E-05 |
| Normal-vs-Age(41-60Yrs) |
1.46040000004177E-06 |
| Normal-vs-Age(61-80Yrs) |
2.13349999999002E-05 |
| Normal-vs-Age(81-100Yrs) |
1.390480E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.521600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.346000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.522000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.807600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.983200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.793400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.10210000014987E-08 |
| Classical-VS-Follicular |
4.475800E-02 |
| Classical-VS-Other |
5.582400E-01 |
| Classical-VS-Normal |
1.56301999999497E-05 |
| Tall-VS-Follicular |
1.20930000457875E-08 |
| Tall-VS-Other |
4.534300E-02 |
| Tall-VS-Normal |
1.50389700692699E-11 |
| Follicular-VS-Other |
2.815800E-01 |
| Follicular-VS-Normal |
7.322100E-03 |
| Other-VS-Normal |
2.444100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.020750E-04 |
| Normal-vs-N1 |
1.54149999986863E-07 |
| N0-vs-N1 |
8.378200E-03 |
|
|
